fluoxetine and amibegron

fluoxetine has been researched along with amibegron in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alonso, R; Avenet, P; Bergis, O; Cohen, C; Decobert, M; Françon, D; Griebel, G; Keane, P; le Fur, G; Lopez-Grancha, M; Pichat, P; Santucci, V; Scatton, B; Stahl, SM; Stemmelin, J; Terranova, JP	1
Aubin, N; Avenet, P; Bougault, I; Busch, S; Chen, Y; Claustre, Y; Desvignes, C; Didier, M; Keane, P; Le Fur, G; Leonetti, M; Oury-Donat, F; Palejwala, V; Rouquier, L; Santucci, V; Scatton, B; Steinberg, R; Tocci, M; Yamdagni, P	1

Other Studies

2 other study(ies) available for fluoxetine and amibegron

Article	Year
Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2008, Volume: 33, Issue:3 Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Aggression; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Behavior, Animal; Cognition; Depressive Disorder; Diazepam; Ethanol; Exploratory Behavior; Fluoxetine; Gerbillinae; Imipramine; Interpersonal Relations; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Adrenergic, beta-3; Sleep; Substance-Related Disorders; Swimming; Tetrahydronaphthalenes	2008
Effects of the beta3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: relevance to its antidepressant/anxiolytic-like profile. Neuroscience, 2008, Oct-02, Volume: 156, Issue:2 Topics: Action Potentials; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Brain; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Fluoxetine; Male; Mice; Microdialysis; Morpholines; Motor Activity; Neurons; Norepinephrine; Rats; Reboxetine; Receptors, Adrenergic, beta-2; Selective Serotonin Reuptake Inhibitors; Serotonin; Tetrahydronaphthalenes; Tryptophan	2008

Article

Year

Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2008, Volume: 33, Issue:3

Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Aggression; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Behavior, Animal; Cognition; Depressive Disorder; Diazepam; Ethanol; Exploratory Behavior; Fluoxetine; Gerbillinae; Imipramine; Interpersonal Relations; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Adrenergic, beta-3; Sleep; Substance-Related Disorders; Swimming; Tetrahydronaphthalenes

2008

Effects of the beta3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: relevance to its antidepressant/anxiolytic-like profile.

Neuroscience, 2008, Oct-02, Volume: 156, Issue:2

Topics: Action Potentials; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Brain; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Fluoxetine; Male; Mice; Microdialysis; Morpholines; Motor Activity; Neurons; Norepinephrine; Rats; Reboxetine; Receptors, Adrenergic, beta-2; Selective Serotonin Reuptake Inhibitors; Serotonin; Tetrahydronaphthalenes; Tryptophan

2008